Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cameroon PCPI Study
NCT06173206Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfadoxine + pyrimethamine in malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Jun 2024; status: completed.
02
Drugs
sulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT06173206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06173206.